← Back to front page
United States · Platforms & data · Finviz

Relmada Therapeutics to Report Third Quarter 2026 Financial Results on Thursday, November 12, 2026

Published by Finviz · United States 20 h ago

Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology and central nervous…

Read the full article on Finviz Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (finviz.com)

Also worth reading

MarketWatch

Big Tech’s $500 billion spending spree leaves a lot less for shareholders

 Seeking Alpha

ConocoPhillips Q3 preview: High expectations as upstream focus drives growth

 The Motley Fool

IPG Photonics: 3 Key Takeaways for Long-Term Investors

 Investing.com

Democrats win control of Congress as voters rebuke Trump agenda

 CNBC

Treasury yields fall after Democrats win House and Senate majorities

 Benzinga

Best Stocks Under $5